Nextage Therapeutics Ltd. is Israel’s leading CDMO with 20 years of exceptional track record, 15,000sqf cGMP and ISO-13485 compliant manufacturing facilities, trusted by more than 400 customers and having extensive experience in more than 3000 projects, including 200 innovative drug products and medical devices. The company provides development and commercial manufacturing services for pharmaceuticals and medical devices across a broad range of technologies and dosage forms, including small molecule drug substance synthesis, formulation development, scale-up and sterile manufacturing, from preclinical development through clinical trials and commercial supply.

Company (Headquarters):

Israel

Types of Drugs Manufactured:

Small Molecule;Medical Devices;Nutraceuticals

CDMO Services:

Drug Product/FDF;Research & Development;Analytical Development;Packaging (Clinical);Process & Forumulation Development

CDMO Number of Facilities:

1

Regulatory Approvals for facilities:

USA – FDA;Europe – EMA or constituent countries;GMP;ISO 13485